Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Care Reform: Plan for Quick Action Dashed By Daschle Withdrawal

Executive Summary

The Obama Administration's formula for making comprehensive health care reform work in 2009 was straightforward: have an experienced team in place in all of the relevant health and budget areas immediately; prepare a manageable piece of legislation for early in the first year; and rely on the political clout of the perfect political general to keep Congress focused and in line

You may also be interested in...



Health Reform Czar DeParle Has Medicare Experience, Budget Pragmatism

The choice of former Medicare chief Nancy-Ann DeParle to head up the White House Office of Health Care Reform indicates that the Obama administration's fall-back strategy for managing health reform emphasizes budget and Medicare/Medicaid experience over political heft

Health Reform Czar DeParle Has Medicare Experience, Budget Pragmatism

The choice of former Medicare chief Nancy-Ann DeParle to head up the White House Office of Health Care Reform indicates that the Obama administration's fall-back strategy for managing health reform emphasizes budget and Medicare/Medicaid experience over political heft

Lambrew’s Departure Would Leave Clean Slate For Incoming Health Czar

Expected departure of second highest ranking official in White House Office of Health Care Reform gives Obama administration flexibility in choosing new top officials.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel